| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/05/2014 | EP2691421A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 02/05/2014 | EP2691401A1 Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque |
| 02/05/2014 | EP2691120A2 Theranostic imaging agents and methods of use |
| 02/05/2014 | EP2691116A1 Nanoparticles loaded with chemotherapeutic antitumoral drug |
| 02/05/2014 | EP2691079A2 Biodegradable compositions suitable for controlled release |
| 02/05/2014 | EP2691078A1 Biodegradable compositions suitable for controlled release |
| 02/05/2014 | EP2691007A1 Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete oct retinal layers |
| 02/05/2014 | CN103555672A Coxsackie virus A16 type mouse-adapted strain and application thereof |
| 02/05/2014 | CN103553130A Cu3BiS3 ternary sulfur nano material and preparation method thereof |
| 02/05/2014 | CN103550834A Embolism material composition as well as preparation method and use thereof |
| 02/05/2014 | CN103550832A Embolism material composition as well as preparation method and use thereof |
| 02/05/2014 | CN103550794A Preparation method of concave ferric oxide T2 dark field magnetic resonance imaging contrast agent |
| 02/05/2014 | CN103550793A Magnetic nano material, preparation method and application of magnetic nano material in magnetic resonance contrast imaging |
| 02/05/2014 | CN103550792A Difunctional nanoprobe for detecting mitochondrial cytochrome C as well as preparation method thereof |
| 02/05/2014 | CN103550791A Preparation and application of water-soluble magnetic targeting carbon composite material |
| 02/05/2014 | CN103550790A Applications of Periostin gene and Periostin antibody in preparation of medicaments |
| 02/04/2014 | US8642561 Peptides whose uptake by cells is controllable |
| 02/04/2014 | US8642257 Vaccinia virus for diagnosis and therapy of tumors |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642013 Nano-scale contrast agents and methods of use |
| 02/04/2014 | US8642012 Methods of treatment using ammonia-scavenging drugs |
| 02/04/2014 | US8642011 Tuberculosis vaccine |
| 02/04/2014 | US8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 02/04/2014 | US8642009 Diagnostic system for the detection of skin cancer |
| 02/04/2014 | CA2687178C Polymeric carriers for immunohistochemistry and in situ hybridization |
| 01/30/2014 | WO2014016455A1 Variants of the calcium-sensitive fusion protein tdtomato-aequorin |
| 01/30/2014 | WO2014015422A1 Cellulose-based nanoparticles for drug delivery |
| 01/30/2014 | WO2013184786A3 Contrast agents, methods for preparing contrast agents, and methods of imaging |
| 01/30/2014 | US20140033332 Methods for monitoring physiological status of a body organ |
| 01/30/2014 | US20140030193 Cuinse/zns nir-quantum dots (qds) for biomedical imagiing |
| 01/29/2014 | CN103547573A Preparation of high-purity gadobutrol |
| 01/29/2014 | CN103547290A Targeted contrast agents and uses thereof |
| 01/29/2014 | CN103540563A Nano probe transfected adipose-derived cell and application thereof in preparing MRI (magnatic resonance imaging) dynamic tracer |
| 01/29/2014 | CN103539799A Preparation method and application of water-soluble aminopolycarboxylic acid modified phthalocyanine compound |
| 01/29/2014 | CN103536972A Magnetic resonance imaging detectable liquid embolism composition and preparation and application thereof |
| 01/29/2014 | CN103536937A Organic-inorganic complex lipid ultrasonography microcapsule and preparation method thereof |
| 01/29/2014 | CN103536936A Carbon nano-tube composite material with fluorescent/ultrasonic dual-mode targeted imaging function, and preparation method and application thereof |
| 01/29/2014 | CN103536935A Photosensitizer-modified core-shell structure magnetic nanocomposites and preparation method and application thereof |
| 01/29/2014 | CN102504603B Conjugate of polymer and biological stain and preparation method and application thereof |
| 01/28/2014 | US8639315 Marker or filler forming fluid |
| 01/28/2014 | US8637252 Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs |
| 01/28/2014 | US8637028 Adjuvant incorporation in immunonanotherapeutics |
| 01/28/2014 | US8636981 Detection of amyloid deposits using anti-amyloid antibodies |
| 01/28/2014 | US8636979 TLR 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries |
| 01/28/2014 | US8636977 Integrin targeted synthetic ligands for diagnostic and therapeutic applications |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/23/2014 | WO2014013732A1 Compound and photoacoustic imaging contrast medium containing the compound |
| 01/23/2014 | WO2014013730A1 Compound and photoacoustic imaging contrast medium containing the compound |
| 01/23/2014 | WO2014013729A1 Contrast agent for photoacoustic imaging |
| 01/23/2014 | WO2014013473A1 Nanoconstructs with pharmacological activity |
| 01/23/2014 | WO2014013272A1 Rhodamine based fluorescent probe for coagulase activity and detection of coagulase producing bacterial strains |
| 01/23/2014 | US20140023594 Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same |
| 01/23/2014 | US20140023593 Immunotherapy for immune suppressed patients |
| 01/23/2014 | US20140023592 Self coupling recombinant antibody fusion proteins |
| 01/23/2014 | US20140023591 Heteromultivalent nanoparticle compositions |
| 01/23/2014 | US20140023590 Novel block copolymer and micelle compositions and methods of use thereof |
| 01/23/2014 | US20140023588 Method of drug delivery by carbon nanotube chitosan nanocomplexes |
| 01/23/2014 | US20140023587 Phospholipid analogs as diapeutic agents and methods thereof |
| 01/23/2014 | US20140023584 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same |
| 01/22/2014 | EP2687235A2 Methods for production and use of substance-loaded erythrocytes (S-LES) for observation and treatment of microvascular hemodynamics |
| 01/22/2014 | EP2687234A1 Silica nanoparticles for diagnostic imaging, method for manufacturing same, and labeling agent for biosubstance |
| 01/22/2014 | EP2686385A2 Activatable fluorogenic compounds and uses thereof as near infrared probes |
| 01/22/2014 | EP2686022A1 Improved glycan arrays and methods for their fabrication |
| 01/22/2014 | CN103520742A Method for improving stability of magnetic nanoparticle contrast agent |
| 01/22/2014 | CN103520741A Preparation method of targeted nuclear magnetism contrast agent |
| 01/22/2014 | CN102925427B Acrylyl lysine translation system and application thereof |
| 01/22/2014 | CN102703081B Water-soluble rare earth doped gadolinium sodium tetrafluoride fluorescent marked nano-crystal, and preparation method thereof |
| 01/22/2014 | CN102604628B Preparation method and applications of organic-inorganic hybrid phosphorescent silica nanoparticles |
| 01/22/2014 | CN102274530B Senile plaque magnetic resonance nano diagnostic reagent and preparation method thereof |
| 01/21/2014 | US8632991 Methods and compositions for treating bleeding disorders |
| 01/21/2014 | US8632751 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/21/2014 | US8632750 Methods for recommending neurophysiological disorder therapy |
| 01/21/2014 | US8632749 Two photon tracer, method for the preparation thereof and the use thereof in screening anticancer agents |
| 01/21/2014 | CA2604034C Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/21/2014 | CA2545066C A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/16/2014 | WO2014012042A1 Intralipid as a contrast agent to enhance subsurface blook flow imaging |
| 01/16/2014 | WO2014010971A1 Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| 01/16/2014 | WO2014009930A1 Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation |
| 01/16/2014 | US20140017175 Pentablock polymers |
| 01/16/2014 | US20140017174 Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
| 01/16/2014 | US20140017173 Process of Evaluating Blood-Brain Barrier Permeability of Stroke Rat by Using Fluorescent Substance |
| 01/16/2014 | US20140017172 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 01/16/2014 | US20140017171 Particle and photoacoustic contrast agent having the particle |
| 01/16/2014 | US20140017169 Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications |
| 01/15/2014 | EP2685260A1 Direct and quantitative detection of targets in living cells |
| 01/15/2014 | EP2684573A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 01/15/2014 | EP2684521A1 Modeling of pharmaceutical propagation |
| 01/15/2014 | EP2683413A1 In vivo selection of therapeutically active antibodies |
| 01/15/2014 | EP2683396A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
| 01/15/2014 | EP2683290A1 Means and methods for in vivo testing of therapeutic antibodies |
| 01/15/2014 | CN103509552A Functional near-infrared fluorescence nanoparticles and preparation and application thereof |
| 01/15/2014 | CN103509366A Dye and method of marking biological material |
| 01/15/2014 | CN103505746A Contrast medium used for glioma targeted magnetic resonance and fluorescence dual modality imaging, and preparation method thereof |
| 01/15/2014 | CN102886048B Building method for medicament transportation or radiography carrier containing coat protein and inorganic nanoparticles |
| 01/15/2014 | CN102557149B Method for preparing water-soluble nanometer iron oxide |
| 01/15/2014 | CN101883785B New non-selective somatostatin analogues |
| 01/15/2014 | CN101612064B Biopsy site marker applier and method |
| 01/14/2014 | US8629318 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation |
| 01/14/2014 | US8629186 Polymer micelles containing anthracyclines for the treatment of cancer |